17β-estradiol, progesterone, and dihydrotestosterone suppress the growth of human melanoma by inhibiting interleukin-8 production

Journal of Investigative Dermatology

Volumn 117, Issue 2, 2001, Pages 274-283

  Kanda, Naoko ^a   Watanabe, Shinichi ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

Receptor; Sex hormone; Transcription

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; CHLORAMPHENICOL ACETYLTRANSFERASE; ESTRADIOL; ESTROGEN RECEPTOR; GROWTH FACTOR; HORMONE RECEPTOR BLOCKING AGENT; INTERLEUKIN 8; MESSENGER RNA; PROGESTERONE; SEX HORMONE; THYMIDINE; TRITIUM; ANTIBODY;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFECT; ENZYME MECHANISM; FEMALE; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; CELL CULTURE; CELL DIVISION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; LYMPHADENECTOMY; MALE; METABOLISM; PHYSIOLOGY; SKIN TUMOR;

ANTIBODIES; CELL DIVISION; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DIHYDROTESTOSTERONE; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GONADAL STEROID HORMONES; HUMANS; INTERLEUKIN-8; LYMPH NODE EXCISION; MALE; MELANOMA; PROGESTERONE; PROMOTER REGIONS (GENETICS); SKIN NEOPLASMS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035542661     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2001.01422.x     Document Type: Article

References (75)

1. Effects of diethylstilbestrol on propionibacterium acnes. Immunomodulation: Inhibition of macrophage activation and antitumor activity
2. Microtubule disruption induced by estradiol in estrogen receptor-positive and -negative human breast cancer cell lines
3. Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level
4. Drug and radiation sensitivity measurements of successful primary monolayer culturing of human tumor cells using cell-adhesive matrix and supplemented medium
5. Clinical evaluation of medroxyprogesterone acetate (MAP) in malignant melanoma
6. Progesterone and 17α-hydroxyprogesterone. Novel stimulators of calcium influx in human sperm
7. Malignant melanoma
8. Evidence for a specific estradiol binding site on rat pituitary membranes
9. Cell surface antigens of human malignant melanoma: Mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells
10. Cell surface antigens of human malignant melanoma: Mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells
11. Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma
12. Brief communication: In vitro effects of melanocyte-stimulating hormone, adrenocorticotropic hormone, 17β-estradiol, or testosterone propionate on Cloudman S91 melanoma cells
13. Estrogen receptor status in malignant melanoma
14. Phase III clinical trial of the combination of cisplatin, dacarbazine, and carmustine with or without tamoxifen in patients with advanced malignant melanoma
15. cis- and trans-acting regulation of gene expression of equine infectious anemia virus
16. Does pregnancy influence the prognosis of malignant melanoma?
17. Estrogen and progesterone receptor analysis in pregnancy-associated melanoma: Absence of immunohistochemically detectable hormone receptors
18. Estrogen receptor and binding site for estramustine in metastatic malignant melanoma
19. Effect of 17β-estradiol on the growth of estrogen receptor-positive human melanoma in vitro and in athymic mice
20. Human oestrogen receptor cDNA. Sequence, expression and homology to v-erb-A
21. A versatile in vivo eukaryotic expression vector for protein engineering
22. Enhancement of tumor metastasis and suppression of natural killer cell activity by β-estradiol treatment
23. 3 and a variety of its natural metabolites transcriptionally repress nuclear-factor-kB-mediated interleukin-8 expression
24. Human melanoma: Development and progression
25. Melanoma and pregnancy
26. Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen
27. Suppression of interleukin-8 production by progesterone in rabbit uterine cervix
28. Phase I clinical study of 6a-methylpregn-4-ene-3,11,20-trione (NSC-17256)
29. Negative interaction between the Re1A (p65) subunit of NF-kB and the progesterone receptor
30. Estrogen and progesterone receptors and tamoxifen in malignant melanoma
31. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B
32. Inhibition of NFkB activity through maintenance of IkBa levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter
33. The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters
34. Synergistic transcriptional activation of the IL-8 gene by NF-kB p65 (Re1A) and NF-IL-6
35. Autocrine and paracrine regulation by cytokines and growth factors in melanoma
36. Synergistic antitumor effects of a combination of interferon and tamoxifen on estrogen receptor-poritive and receptor-negative human tumor cell lines in vivo and in vitro
37. Effect of estrogen on the growth of B-16 melanoma
38. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis
39. Interaction with fibronectin regulates cytokine gene expression in human melanoma cells
40. For the world health organization melanoma programme: Lack of effect of pregnancy on the outcome of melanoma
41. Molecular control of immune/inflammatory responses: Interactions between nuclear factor-kB and steroid receptor-signaling pathways
42. Activation of nuclear factor-kB in human metastatic melanoma cells and the effect of oxidative stress
43. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells
44. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8
45. Novel mechanism of glucocorticoid-mediated gene repression
46. Endocrinology of melanoma
47. Steroid hormone receptors and melanoma
48. The prognosis for malignant melanoma in the pregnant woman
49. Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding
50. Androgens regulate bone resorption activity of isolated osteoclasts in vitro
51. Tamoxifen and quercetin interact with type II estrogen binding sites and inhibit the growth of human melanoma cells
52. 17β-estradiol inhibits expression of human interleukin-6 promoter-receptor constructs by a receptor-dependent mechanism
53. Selective binding of steroid hormone receptors to octamer transcription factors determines transcriptional synergism at the mouse mammary tumor virus promoter
54. Brief communication: Endocrine factors and the growth and spread of B16 melanoma
55. Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine
56. Malignant melanoma: Sex differences in survival after evidence of distant metastasis
57. Regulation of interleukin-8 gene expression
58. The malignant melanoma of hamsters: III Effects of sex and castration on the growth of the transplanted tumor
59. The attractions of proteins for small molecules and ions
60. IL- 8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor
61. Inhibition of hamster growth by estrogen
62. Endocrine influences on survival from malignant melanoma
63. Role of growth factors and their receptors in the development and progression of melanoma
64. Adverse effect of pregnancy on melanoma. A reappraisal
65. Transcriptional activation and nuclear targeting signals of the human androgen receptor
66. Tissue-specific and androgen-repressible regulation of the rat dehydroepiandrosterone sulfotransferase gene promoter
67. Cross-coupling of the NF-kB p65 and Fos/Jun transcription factors produces potentiated biological function
68. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kB and C/EBPβ
69. Estrogen inhibits phorbol ester-induced IkBα transcription and protein degradation
70. 1a,25-dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF- 7 human breast cancer cells
71. Estrogen receptor in malignant melanoma
72. Prognostic significance of pregnancy in stage I melanoma
73. Oct-1 and CCAAT/enhancer-binding protein (C/EBP) bind to overlapping elements within the interleukin- 8 promoter
74. Expression and secretion of leukocyte chemotactic cytokines by normal human melanocytes and melanoma cells
75. A nonsteroidal anti-inflammatory drug, flufenamic acid, inhibits the expression of the androgen receptor in LNCaP cells